Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 4/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.35 |
| ▸ | MAPT | P10636 | 5/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.33 |
| ▸ | ATM | Q13315 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.32 |
| ▸ | USP2 | O75604 | 2/20 | 0.32 |
| ▸ | LMNA | P02545 | 2/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.31 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.31 |
| ▸ | THRB | P10828 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | CASP1 | P29466 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2471874 | 0.85 | MEN1 (0.36) | MEN1KMT2ATDP1MAPTKDM4E | |
| SCHEMBL6088109 | 0.82 | KMT2A (0.37) | MEN1KMT2ATDP1MAPTKDM4E | |
| SCHEMBL12752174 | 0.80 | KMT2A (0.40) | MEN1KMT2ATDP1MAPTKDM4E | |
| SCHEMBL6089258 | 0.80 | KMT2A (0.41) | MEN1KMT2AMAPTKDM4EATM | |
| SCHEMBL12752290 | 0.79 | B3GNT2 (0.41) | MEN1KMT2ATDP1MAPTKDM4E | |
| SCHEMBL12752183 | 0.79 | KMT2A (0.47) | MEN1KMT2ATDP1MAPTKDM4E | |
| SCHEMBL2469145 | 0.78 | ALDH1A1 (0.32) | MEN1KMT2AMAPTALDH1A1HSD17B10 | |
| SCHEMBL2470798 | 0.78 | ALDH1A1 (0.32) | MAPTALDH1A1HSD17B10SMN1; SMN2ALOX15 | |
| SCHEMBL12752190 | 0.78 | KMT2A (0.39) | MEN1KMT2ATDP1MAPTALDH1A1 | |
| SCHEMBL6088185 | 0.78 | KMT2A (0.37) | MEN1KMT2ATDP1MAPTALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250255968-A1 | INTRAVAGINAL DEVICES FOR DRUG DELIVERY | KISER PATRICK F (US) | 2025-08-14 | — | — | US | claimed |
| EP-2734262-B1 | INTRAVAGINAL RINGS FOR DRUG DELIVERY | KISER PATRICK F (US) | 2018-02-28 | — | — | EP | claimed |
| US-20140209100-A1 | INTRAVAGINAL DEVICES FOR DRUG DELIVERY | Kiser, Patrick F. | 2014-07-31 | — | — | US | claimed |
| EP-2734262-A1 | INTRAVAGINAL DEVICES FOR DRUG DELIVERY | Kiser, Patrick F. (US) | 2014-05-28 | — | — | EP | claimed |
| US-20130220337-A1 | DEVICES AND METHODS FOR INTRAVAGINAL DELIVERY OF DRUGS AND OTHER SUBSTANCES | KISER PATRICK F (US) | 2013-08-29 | — | — | US | claimed |
| EP-2605779-A2 | DEVICES AND METHODS FOR INTRAVAGINAL DELIVERY OF DRUGS AND OTHER SUBSTANCES | The University of Utah Research Foundation (US) | 2013-06-26 | — | — | EP | claimed |
| WO-2013013172-A1 | INTRAVAGINAL DEVICES FOR DRUG DELIVERY | THE UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) | 2013-01-24 | — | — | WO | claimed |
| WO-2012024605-A2 | DEVICES AND METHODS FOR INTRAVAGINAL DELIVERY OF DRUGS AND OTHER SUBSTANCES | THE UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) | 2012-02-23 | — | — | WO | claimed |
| EP-1986651-B1 | USE OF A PYRIMIDINEDIONE DERIVATIVE FOR PREVENTING OR TREATING HEPATITIS C | SAMJIN PHARM CO LTD (KR) | 2011-10-05 | — | — | EP | claimed |
| US-20110045076-A1 | LINEAR ORDER RELEASE POLYMER | THE UNIVERSITY OF UTAH RESEARCH FOUNDATION | 2011-02-24 | — | — | US | claimed |
| US-7851479-B2 | Use of pyrimidinedione derivative for preventing or treating hepatitis C | SAMJIN PHARM. CO., LTD. (KR) | 2010-12-14 | — | — | US | claimed |
| EP-2244782-A2 | LINEAR ORDER RELEASE POLYMER | The University of Utah Research Foundation (US) | 2010-11-03 | — | — | EP | claimed |
| WO-2009094573-A9 | LINEAR ORDER RELEASE POLYMER | THE UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) | 2010-09-16 | — | — | WO | claimed |
| WO-2009094573-A2 | LINEAR ORDER RELEASE POLYMER | THE UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) | 2009-07-30 | — | — | WO | claimed |
| US-20090023764-A1 | Use of Pyrimidinedione Derivative for Preventing or Treating Hepatitis C | SAMJIN PHARM. CO., LTD. (KR) | 2009-01-22 | — | — | US | claimed |
| US-20250255968-A1 | INTRAVAGINAL DEVICES FOR DRUG DELIVERY | KISER PATRICK F (US) | 2025-08-14 | — | — | US | disclosed |
| EP-2734262-B1 | INTRAVAGINAL RINGS FOR DRUG DELIVERY | KISER PATRICK F (US) | 2018-02-28 | — | — | EP | disclosed |
| WO-2009094573-A2 | LINEAR ORDER RELEASE POLYMER | THE UNIVERSITY OF UTAH RESEARCH FOUNDATION (US) | 2009-07-30 | — | — | WO | disclosed |
| US-20090023764-A1 | Use of Pyrimidinedione Derivative for Preventing or Treating Hepatitis C | SAMJIN PHARM. CO., LTD. (KR) | 2009-01-22 | — | — | US | disclosed |
| US-20090023764-A1 | Use of Pyrimidinedione Derivative for Preventing or Treating Hepatitis C | SAMJIN PHARM. CO., LTD. (KR) | 2009-01-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090023764-A1 | Use of Pyrimidinedione Derivative for Preventing or Treating Hepatitis C | DPYD, UMPS, TYMP | MEN1 4693/4885KMT2A 4444/4885TDP1 757/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.